Table of Contents

Structure and Function of Dipeptidyl Aminopeptidases.- Dipeptidyl Peptidase IV Substrates.- Structure-Function Relationship of DPP IV: Insights into its Dimerisation and Gelatinase Activity.- Exploration of the Active Site of Dipeptidyl Peptidase IV From Porphyromonas gingivalis.- Modification of the Biological Activity of Chemokines by Dipeptidyl Peptidase IV — a Side Effect in the Use of Inhibitors?.- Molecular Chimeras and Mutational Analysis in the Prolyl Oligopeptidase Gene Family.- The Specificity of DP IV for Natural Substrates is Peptide Structure Determined.- New Results on the Conformations of Potent DP IV (CD26) Inhibitors bearing the N-terminal MWP Structural Motif.- Different Inhibition Mechanisms of Dipeptidyl Peptidase IV by Tryptophan Containing Peptides and Amides.- Re-Uptake Mechanisms of Peptide Fragments after DPP IV-Mediated Proteolysis in the Peripheral Nervous System.- DPP IV-Like Enzymes.- Dipeptidyl Peptidase IV Gene Family.- Seprase-DPPIV Association and Prolyl Peptidase and Gelatinase Activities of the Protease Complex.- Dipeptidyl Peptidase-IV Activity and/or Structure Homologues (DASH) in Transformed Neuroectodermal Cells.- Characterisation of Human DP IV Produced by a Pichia pastoris Expression System.- Isolation and Characterization of Attractin-2.- Investigation of DP IV-dependent Protein-Protein Interactions using Surface Plasmon Resonance.- Immune Mechanisms and Immune Disorders.- Synergistic Action of DPIV and APN in the Regulation of T Cell Function.- CD26/DPP IV in Experimental and Clinical Organ Transplantation.- CD26 is Involved in the Regulation of T-Cell Plasma Membrane Compartmentation.- Inhibition of Dipeptidylpeptidase IV (DPP IV, CD26) Activity Modulates Surface Expression of CTLA-4 in Stress-Induced Abortions.- DipeptidylPeptidase IV/CD26 in T Cell Activation, Cytokine Secretion and Immunoglobulin Production.- Dipeptidyl Peptidase IV Inhibitors with the N-terminal MXP Sequence: Structure-Activity-Relationships.- On the Role of Dipeptidyl Peptidase IV in the Digestion of an Immunodominant Epitope in Celiac Disease.- The Properties of Human and Bovine CD8+CD26+ T Cells Induced by a Microbial Superantigen.- Angiogenesis and Cancer.- DPPIV and Seprase in Cancer Invasion and Angiogenesis.- Glutamate Carboxypeptidase II Inhibition as a Novel Therapeutic Target.- Dual Role of Dipeptidyl Peptidase IV (DPP IV) in Angiogenesis and Vascular Remodeling.- CD26 Expression on Cutaneous Infiltrates from Patients with Cutaneous T-Cell Lymphoma (CTCL).- Intrahepatic Expression of Collagen and Fibroblast Activation Protein (FAP) in Hepatitis C Virus Infection.- Expression of CD26/Dipeptidyl Peptidase IV in Endometrial Adenocarcinoma and its Negative Correlation with Tumor Grade.- Adhesion Potency to Mesothelial Cells by Overexpression of Dipeptidyl Peptidase IV.- Survival Time and Invasive Activity due to Dipeptidyl Peptidase IV Overexpression in Ovarian Carcinoma.- Dipeptidylpeptidase IV Activities in Prostatic Secretions.- Diabetes and Metabolism.- Implementation of GLP-1 Based Therapy of Type 2 Diabetes Mellitus Using DPP-IV Inhibitors.- Dipeptidyl Peptidase IV Inhibition in Animal Models of Diabetes.- Glucose-dependent Insulinotropic Polypeptide (GIP): Development of DP IV-Resistant Analogues with Therapeutic Potential.- Neutral Endopeptidase 24.11 and Dipeptidyl Peptidase IV are Both Involved in Regulating the Metabolic Stability of Glucagon-like Peptide-1 in vivo.- DPP IV, Immune Parameters, and Psychometrical Variables in Patients with Eating Disorders.- DPP IV and Mental Depression in Crohn’sDisease.- Microscopic Acid-Base Equilibra of Alanyl-boroAlanine.- Acylated Hydroxamates as Selective and Highly Potent Inhibitors of Dipeptidyl Peptidase I.- CD26-/DPP IV-Positive Lymphocytes in Murine Acute Experimental Colitis.- Neuroprotective Effects of Inhibitors of Dipeptidyl Peptidase-IV In Vitro and In Vivo.